Delivery Order SPE2DB25D3201-SPE2DB26FNNUU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This order, valued at $5,621.13, represents a firm fixed-price delivery order with an ultimate completion date of November 4, 2025. The contract was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $5,056.95 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and was awarded on September 3, 2025. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for Terbinafine HCL 250 mg tablets (90-count supply) valued at $4,586.12. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside award for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $2,964.57. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract is expected to be completed by September 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 tablets, with a ceiling value of $4,397.88. This non-competitive, firm fixed-price delivery order is set to be completed by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 with a ceiling value of $5,904.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,017.90 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count). This competitively awarded, firm fixed-price contract was finalized on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order valued at $11,112.30 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a completion date of July 31, 2025. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,165.31 on August 8, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNUUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, valued at $36,969.40. This firm fixed-price contract, with an ultimate completion date of November 4, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the nation's largest pharmaceutical distributors serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to the U.S. military and Defense Health Agency. The underlying IDC enables the contractor to deliver a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen's track record of competitive awards and substantial contract values demonstrates its established capability to fulfill critical federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.0k | 11/3/25 |